"My experience with the staff at hict has been very positive. Their insights and analyses are helping us quantify and communicate the value of important attributes of our product."
Publications
Clients quote
Sean Robbins, International Health Economics & Reimbursement, Amgen Europe
- Burnier M., Demey J., Tanghe A., Douchamps J. Improving Anemia Management with Less Frequently Dosed Erythropoiesis Stimulating Agents. ERA-EDTA XLIV Congress, Barcelona, June 2007.
- Tanghe A., Rooryck N., Legrand M., Demey J. Economic Benefits of Less Frequent Dosing of Erythropoietic Stimulating Proteins in Patients on Dialysis. European Society of Clinical Pharmacy, Vienna, October 2006.
- Burnier M., Teta D., Oudy C., Demey J., Tanghe A. Potential Contribution of Every Other Week Administered Erythropoiesis Stimulating Agents to the Operational Efficiency of Anemia Management in a Haemodialysis Center: an Explorative Pilot Study in a Haemodialysis Center in Switzerland. 38th Annual Meeting Swiss Society of Nephrology, Solothurn, December 2006.
- Burnier M., Demey J., Tanghe A. Less Frequent Dosing of Erythropoiesis Stimulating Agents may result in cost savings in European Dialysis Centers. American Society of Nephrology - Renal Week 2007, San Francisco, October 2007.
- Fung E., Musing E., Tanghe A., Butaye K. Process Flow for Erythropoiesis Stimulating Agents (ESA) Delivery to Haemodialysis (HD) Patients at Toronto General Hospital - Process Optimization and Impact Analysis of Alternative Dosing Frequencies. Summer Educational Sessions Canadian Society of Hospital Pharmacists, Winnipeg, August 2009.
- Burnier M., Martin P.-Y., Binet I., Tsinalis D., Kistler T., Tanghe A., Demey J.Potential contribution of less frequently dosed erythropoiesis stimulating agents (ESA) to the operational efficiency of anaemia management: A study in 4 Swiss haemodialysis centres. 39th Annual Meeting Swiss Society of Nephrology, Lausanne, December 2007.
- Legrand M., Coudron V., Taillieu I., Rooryck N., Dupont K., Boudrez P., Senn A., Vinck I., Peeters G., Kohn L. Videoregistratie van endoscopische chirurgische interventies: rapid assessment. KCE reports 101A, 2008.
- Szucs T., Bauwens J., Alfonso J.E., Holthuis N., Von Knorring J., Demey J. Development of a time-driven activity-based costing model for assessing the societal acquisition cost of erythrocyte concentrate in Europe. 14th Congress of European Hematology Association, Berlin, 2009.
- Garcia-Erce J.A., Bisbe E., Alfonso E., Muñoz M.. The ‘true’ costs of blood: The average unit production cost of an erythrocyte concentrate in Spain from a societal perspective. NATA Symposium, 2010.
- Burnier M., Douchamps J. A., Tanghe A., Demey J., Perrault L., Foster C. E., Robbins S. Less frequent dosing of erythropoiesis stimulating agents in patients undergoing dialysis: a European multicentre cost study. Journal of Medical Economics, 2009.
Ezelstraat 69 | B- 8000 Brugge | Belgium | Phone: +32.50.33.33.40 | Fax: +32.50.33.33.39 | RPR/RPM: 0866 039 556 | e-mail: info@hict.com